Đăng xuất
Alcohol: Precaution is recommended with intake of alcohol (see Interactions).
Risk of urinary retention: Caution should be taken in patients with predisposing factors of urinary retention (e.g. spinal cord lesion, prostatic hyperplasia) as levocetirizine may increase the risk of urinary retention.
Infants and children under 2 years: Even if some clinical data are available in children aged 6 months to 12 years (see Pharmacology: Pharmacodynamics under Actions and Adverse Reactions), these data are not sufficient to support the administration of levocetirizine to infants and toddlers aged less than 2 years.
Therefore the administration of levocetirizine to infants and toddlers aged less than 2 years is not recommended.
Lactose: This medicinal product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Effects on Ability to Drive and Use Machines: Comparative clinical trials have revealed no evidence that levocetirizine at the recommended dose impairs mental alertness, reactivity or the ability to drive. Nevertheless, some patients could experience somnolence, fatigue and asthenia under therapy with levocetirizine. Therefore, patients intending to drive, engage in potentially hazardous activities or operate machinery should take their response to the medicinal product into account.
Use in Children: Children aged less than 6 years: The use of the film-coated tablet formulation is not recommended in children aged less than 6 years since this formulation does not allow for appropriate dose adaptation. It is recommended to use a peadiatric formulation of levocetirizine.
